Entering text into the input field will update the search result below

Chemomab Therapeutics chief medical officer resigns

Dec. 03, 2021 8:49 AM ETChemomab Therapeutics Ltd. (CMMB)By: Dulan Lokuwithana, SA News Editor
  • Chemomab Therapeutics (NASDAQ:CMMB) announced that David M. Weiner has been appointed as the company’s Interim Chief Medical Officer, effective immediately.
  • The appointment made on a part-time basis follows the resignation of current Chief Medical Officer Arnon Aharon. However, for a smooth transition

This was corrected on 12/03/2021 at 9:37 AM. This post was corrected to add the correct ticker symbol for Chemomab.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.